Beijing Biostar Technologies Goes Public in Hong Kong to Fund Cancer Drug Development
Beijing Biostar Technologies Ltd (HKG: 2563), a leading synthetic biology-driven anti-tumor drug specialist based in...
Finance
Macrolux Raises Over RMB 100 Million in Series B Financing
Macrolux, a leading medical technology company specializing in disposable endoscopes, has announced the completion of...
Otsuka Holdings Weighs Sale of Stake in Medical Device Maker MicroPort Scientific
Otsuka Holdings Co., a Japanese pharmaceutical and healthcare company, is reportedly considering the sale of...
Stem-Cell Startup Xellsmart Secures Over RMB 100 Million in Series B1 Financing for Neurological Therapies
Xellsmart, a stem-cell startup headquartered in Suzhou, has reportedly secured over RMB 100 million (USD...
Beijing Biostar Pharmaceuticals Set to Go Public on HKEX with Focus on Oncology Innovation
On October 18, 2024, the Hong Kong Stock Exchange announced that Beijing Biostar Pharmaceuticals Co.,...
LaNova Medicines Secures RMB 300 Million in Series C1 Financing to Advance Cancer Therapy Pipeline
LaNova Medicines Ltd, a Shanghai-based developer of cancer therapies, has announced the successful completion of...
TenNor Therapeutics Secures USD 42.16 Million in Series E Financing for Antibacterial Pipeline
TenNor Therapeutics, a clinical-stage pharmaceutical company based in China, has announced the successful completion of...
iRegene Therapeutics Secures Over USD 14 Million in Series B Financing to Advance Cell Therapies
iRegene Therapeutics, a Wuhan-based biotechnology company specializing in the development of AI-enhanced chemically induced cell...
Akeso Biopharma Secures USD 250 Million in Share Placement, Bolstering Drug Development War chest
Akeso Biopharma (HKG: 9926), a biopharmaceutical company based in China, has declared the successful completion...
Beijing Aosaikang Pharmaceuticals Boosts Stake in US Subsidiary AskGene with RMB 220 Million Investment
Beijing Aosaikang Pharmaceutical Co., Ltd (SHE: 002755) has announced a capital injection of RMB 220...
Kailera Therapeutics Emerges with USD 400 Million in Series A Funding for Anti-Obesity Pipeline
Kailera Therapeutics, a newly launched US-based biotechnology company, secured USD 400 million in Series A...
Genor Biopharma to Acquire EOC Pharma Group in a Merger Deal, Eyeing Commercialization Synergies
Genor Biopharma Holdings Limited (HKG: 6998) has announced a definitive merger agreement with EOC Pharma...
Zephyrm Bioscience Aims for HKEX Main Board with Innovative Cell Therapy Products
Zephyrm Bioscience Limited (hereinafter referred to as “Zephyrm Bio”) officially submitted its prospectus to the...
Whittilong Pharma Secures Over RMB 100 Million in Series B Financing for Modified Drug Development
Whittilong Pharma, a Shanghai-based modified drug development company backed by Shanghai Healthcare Capital (SHC), has...
2seventy bio and BMS Discontinue Phase III Trial for Multiple Myeloma Therapy Abecma
2seventy bio Inc. (NASDAQ: TSVT), a U.S.-based biotechnology company partnered with Bristol-Myers Squibb (BMS, NYSE:...
Johnson & Johnson Reportedly Winding Down Cardiovascular and Metabolic Pharma Unit
Johnson & Johnson (J&J; NYSE: JNJ), a healthcare giant in the U.S., is reportedly winding...
Longbio Pharma Secures RMB 100 Million in Series B2 Financing to Advance Clinical Programs
Longbio Pharma, a biopharmaceutical company specializing in biomacromolecule drug development and based in Shanghai, China,...
Apeloa Pharmaceutical Invests in Ji Xing Pharmaceuticals’ Series D Financing Round
China-based Apeloa Pharmaceutical Co., Ltd (SHE: 000739) has announced its participation in the Series D...
Organon Inks Deal to Acquire Dermavant, Bolstering Dermatology Portfolio with Vtama Cream
US healthcare company Organon (NYSE: OGN) has announced a definitive agreement to acquire Dermavant, a...
Beijing’s MoleculeMind Secures Series A Funding to Accelerate AI Protein Design Innovations
MoleculeMind, a Beijing-based AI protein design platform, has reportedly secured a Series A financing round,...